These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 23229803

  • 41. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ, Laurensse E, Leyva A, Lankelma J, Pinedo HM.
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [Abstract] [Full Text] [Related]

  • 42. [Expression of mRNA levels of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in diffusely infiltrating colorectal cancer].
    Ishibashi K, Sobajima J, Ohsawa T, Yokoyama M, Miyazaki T, Nakada H, Gonda T, Ishida H.
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1073-7. PubMed ID: 17637543
    [Abstract] [Full Text] [Related]

  • 43. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
    Schüller J, Cassidy J, Dumont E, Roos B, Durston S, Banken L, Utoh M, Mori K, Weidekamm E, Reigner B.
    Cancer Chemother Pharmacol; 2000 Jul; 45(4):291-7. PubMed ID: 10755317
    [Abstract] [Full Text] [Related]

  • 44. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV.
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas.
    Maehara Y, Moriguchi S, Emi Y, Watanabe A, Kohnoe S, Tsujitani S, Sugimachi K.
    Cancer; 1990 Jul 01; 66(1):156-61. PubMed ID: 2162241
    [Abstract] [Full Text] [Related]

  • 49. Real-time RT-PCR (TaqMan) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil.
    Kubota T.
    Methods Mol Med; 2005 Jul 01; 111():257-65. PubMed ID: 15911984
    [Abstract] [Full Text] [Related]

  • 50. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H, Shirakawa K, Ohsawa T, Sobajima J, Hayashi Y, Nakada H, Yokoyama M, Hashimoto D.
    Gan To Kagaku Ryoho; 2005 Nov 01; 32(12):1929-34. PubMed ID: 16282729
    [Abstract] [Full Text] [Related]

  • 51. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
    Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR.
    J Clin Oncol; 2005 Dec 01; 23(34):8679-87. PubMed ID: 16314628
    [Abstract] [Full Text] [Related]

  • 52. Thymidine phosphorylase and dihydropyrimidine dehydrogenase are predictive factors of therapeutic efficacy of capecitabine monotherapy for breast cancer-preliminary results.
    Honda J, Sasa M, Moriya T, Bando Y, Hirose T, Takahashi M, Nagao T, Tangoku A.
    J Med Invest; 2008 Feb 01; 55(1-2):54-60. PubMed ID: 18319546
    [Abstract] [Full Text] [Related]

  • 53. [Thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in soft-tissue sarcoma versus capecitabine potential].
    Stepanova EV, Bokhian BIu, Petrovichev NN, Lichinitzer MR.
    Vopr Onkol; 2005 Feb 01; 51(3):314-6. PubMed ID: 16279094
    [Abstract] [Full Text] [Related]

  • 54. Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
    Nagasaki T, Tsuchiya T, Tagawa T, Honda S, Yamasaki N, Miyazaki T, Hidaka S, Hayashi T, Nagayasu T.
    Clin Lung Cancer; 2010 Nov 01; 11(6):412-22. PubMed ID: 21062732
    [Abstract] [Full Text] [Related]

  • 55. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL, Danenberg KD, Behan K, Parr A, Young L, Danenberg PV, Nguyen D, Drake J, Monks A, Allegra CJ.
    Clin Cancer Res; 2001 Apr 01; 7(4):999-1009. PubMed ID: 11309351
    [Abstract] [Full Text] [Related]

  • 56. Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes.
    Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K.
    Int J Cancer; 2002 May 20; 99(3):328-35. PubMed ID: 11992400
    [Abstract] [Full Text] [Related]

  • 57. Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.
    Chefrour M, Milano G, Formento P, Giacometti S, Denden A, Renée N, Iliadis A, Fischel JL, Ciccolini J.
    Fundam Clin Pharmacol; 2012 Aug 20; 26(4):530-7. PubMed ID: 21623901
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.